BRIGHTSPRING HEALTH SERVICES INC: TD COWEN INCREASES TARGET PRICE FROM $60 TO $65
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 3 days ago
0mins
Should l Buy BTSG?
Source: moomoo
Price Increase Announcement: BrightSpring Health Services has raised its target price to $65 from $60.
Company Overview: BrightSpring Health Services is a provider of health services, focusing on various healthcare solutions.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy BTSG?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on BTSG
Wall Street analysts forecast BTSG stock price to fall
12 Analyst Rating
12 Buy
0 Hold
0 Sell
Strong Buy
Current: 52.740
Low
40.00
Averages
43.20
High
50.00
Current: 52.740
Low
40.00
Averages
43.20
High
50.00
About BTSG
BrightSpring Health Services, Inc. provides complementary home- and community-based pharmacy and provider health solutions for complex populations in need of specialized and/or chronic care. Through the Company’s service lines, including pharmacy, home health care and rehabilitation, it provides comprehensive and more integrated care and clinical solutions in all 50 states to customers, clients and patients. Its services are organized and managed through two reportable segments: Pharmacy Solutions and Provider Services. Pharmacy Solutions segment operates long-term institutional pharmacies, hospice pharmacies, specialty oncology pharmacies, and home infusion centers. It provides infused, injectable, and oral medication services in the home and clinic. Provider Services segment provides a variety of services to help manage the whole-person health of its patients in their homes and communities through services such as home health care and hospice care and long-term specialty care.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
BRIGHTSPRING HEALTH SERVICES INC: TD COWEN INCREASES TARGET PRICE FROM $60 TO $65
Price Increase Announcement: BrightSpring Health Services has raised its target price to $65 from $60.
Company Overview: BrightSpring Health Services is a provider of health services, focusing on various healthcare solutions.
See More
BrightSpring Health Services Q1 2026 Earnings Highlights
- Strong Financial Performance: BrightSpring reported total revenue of $3.6 billion in Q1 2026, reflecting a 26% year-over-year growth, indicating the company's sustained growth potential in the healthcare sector, with full-year revenue expected to range from $14.725 billion to $15.225 billion, showcasing optimism for future market conditions.
- Adjusted EBITDA Growth: The adjusted EBITDA for the first quarter reached $190 million, a 45% increase year-over-year, with an EBITDA margin improving to 5.3%, demonstrating significant progress in cost control and operational efficiency, thereby enhancing the company's financial stability.
- Community Business Sale Proceeds: BrightSpring completed the sale of Community Living on March 30, 2026, generating approximately $811 million in net cash proceeds, which will be utilized for debt repayment and enhancing cash flow, further optimizing the company's capital structure.
- Pharmacy Solutions Outlook: Despite a 9% decline in Home and Community Pharmacy revenue to $527 million, primarily due to IRA impacts, the company continues to maintain healthy growth in its specialty and infusion businesses, expecting to offset this decline through the expansion of LDD product lines and improved patient satisfaction scores.
See More
BrightSpring Health Services Reports Strong Q1 Results and Raises 2026 Guidance
- Financial Performance Growth: BrightSpring achieved net revenue of $3.614 billion in Q1 2026, a 25.6% increase year-over-year, indicating strong demand in the complex health services sector, which is expected to further enhance market share.
- Gross Margin Improvement: The company reported a gross profit of $482 million for Q1, up 42.5% from the same period in 2025, demonstrating significant progress in cost control and service efficiency, which will bolster profitability.
- Significant Net Income Increase: BrightSpring's net income reached $74 million in Q1, a substantial rise from $9 million in Q1 2025, reflecting successful strategies in operational efficiency and market positioning.
- 2026 Guidance Raised: The company has raised its full-year 2026 revenue guidance to between $14.725 billion and $15.225 billion, with expected growth rates of 14.1% to 17.9%, showcasing confidence in future market prospects and a strategic intent for continued expansion.
See More
BrightSpring Health Services Q1 Earnings Exceed Expectations
- Strong Earnings Report: BrightSpring Health Services reported Q1 GAAP EPS of $0.67, beating expectations by $0.40, which reflects a significant improvement in profitability and boosts investor confidence.
- Substantial Revenue Growth: The company achieved Q1 revenue of $3.61 billion, a staggering 129,756.1% year-over-year increase, surpassing market expectations by $220 million, indicating robust performance and growth potential in the market.
- Segment Performance: Pharmacy segment revenue is projected between $12.85 billion and $13.3 billion, reflecting a growth rate of 12.3% to 16.2%, while the provider segment is expected to generate revenue between $1.875 billion and $1.925 billion, with a growth rate of 28% to 31.4%, showcasing strong growth across business lines.
- Positive Future Outlook: The company anticipates adjusted EBITDA of $795 million to $825 million in 2026, representing a growth rate of 28.7% to 33.6%, and the acquisition of Amedysis and LHC is expected to contribute approximately $30 million in adjusted EBITDA in 2026, further enhancing profitability and competitive positioning.
See More
BRIGHTSPRING HEALTH SERVICES INC - Q1 NET REVENUE INCREASES 25.6% TO $3.614 BILLION
- Revenue Growth: BrightSpring Health Services reported a 25.6% increase in net revenue for Q1, reaching $3,614 million.
- Financial Performance: The significant rise in revenue indicates strong financial performance and growth within the health services sector.
See More
BrightSpring Completes Sale of ResCare Community Living to Sevita
- Transaction Background: BrightSpring Health Services has completed the sale of ResCare Community Living, a move that underscores a commitment to continuity of care for individuals with intellectual and developmental disabilities while ensuring workforce stability.
- Strategic Transition Significance: CEO Jon Rousseau stated that the divestiture was aimed at ensuring high-quality, innovative care for clients, marking a strategic shift for both BrightSpring and Sevita as they focus on their respective missions.
- Service Expansion Potential: Sevita CEO Philip Kaufman highlighted that the acquisition will leverage the strengths of both organizations, enhancing programming and expected to benefit more individuals in need of high-quality support, thereby improving overall service quality.
- Industry Impact: BrightSpring serves over 450,000 customers daily and consistently demonstrates industry-leading quality metrics, and this transaction is expected to further solidify its market position in the complex care sector.
See More
BRIGHTSPRING HEALTH SERVICES INC: TD COWEN INCREASES TARGET PRICE FROM $60 TO $65
Price Increase Announcement: BrightSpring Health Services has raised its target price to $65 from $60.
Company Overview: BrightSpring Health Services is a provider of health services, focusing on various healthcare solutions.
See More
BrightSpring Health Services Q1 2026 Earnings Highlights
- Strong Financial Performance: BrightSpring reported total revenue of $3.6 billion in Q1 2026, reflecting a 26% year-over-year growth, indicating the company's sustained growth potential in the healthcare sector, with full-year revenue expected to range from $14.725 billion to $15.225 billion, showcasing optimism for future market conditions.
- Adjusted EBITDA Growth: The adjusted EBITDA for the first quarter reached $190 million, a 45% increase year-over-year, with an EBITDA margin improving to 5.3%, demonstrating significant progress in cost control and operational efficiency, thereby enhancing the company's financial stability.
- Community Business Sale Proceeds: BrightSpring completed the sale of Community Living on March 30, 2026, generating approximately $811 million in net cash proceeds, which will be utilized for debt repayment and enhancing cash flow, further optimizing the company's capital structure.
- Pharmacy Solutions Outlook: Despite a 9% decline in Home and Community Pharmacy revenue to $527 million, primarily due to IRA impacts, the company continues to maintain healthy growth in its specialty and infusion businesses, expecting to offset this decline through the expansion of LDD product lines and improved patient satisfaction scores.
See More
BrightSpring Health Services Reports Strong Q1 Results and Raises 2026 Guidance
- Financial Performance Growth: BrightSpring achieved net revenue of $3.614 billion in Q1 2026, a 25.6% increase year-over-year, indicating strong demand in the complex health services sector, which is expected to further enhance market share.
- Gross Margin Improvement: The company reported a gross profit of $482 million for Q1, up 42.5% from the same period in 2025, demonstrating significant progress in cost control and service efficiency, which will bolster profitability.
- Significant Net Income Increase: BrightSpring's net income reached $74 million in Q1, a substantial rise from $9 million in Q1 2025, reflecting successful strategies in operational efficiency and market positioning.
- 2026 Guidance Raised: The company has raised its full-year 2026 revenue guidance to between $14.725 billion and $15.225 billion, with expected growth rates of 14.1% to 17.9%, showcasing confidence in future market prospects and a strategic intent for continued expansion.
See More
BrightSpring Health Services Q1 Earnings Exceed Expectations
- Strong Earnings Report: BrightSpring Health Services reported Q1 GAAP EPS of $0.67, beating expectations by $0.40, which reflects a significant improvement in profitability and boosts investor confidence.
- Substantial Revenue Growth: The company achieved Q1 revenue of $3.61 billion, a staggering 129,756.1% year-over-year increase, surpassing market expectations by $220 million, indicating robust performance and growth potential in the market.
- Segment Performance: Pharmacy segment revenue is projected between $12.85 billion and $13.3 billion, reflecting a growth rate of 12.3% to 16.2%, while the provider segment is expected to generate revenue between $1.875 billion and $1.925 billion, with a growth rate of 28% to 31.4%, showcasing strong growth across business lines.
- Positive Future Outlook: The company anticipates adjusted EBITDA of $795 million to $825 million in 2026, representing a growth rate of 28.7% to 33.6%, and the acquisition of Amedysis and LHC is expected to contribute approximately $30 million in adjusted EBITDA in 2026, further enhancing profitability and competitive positioning.
See More
BRIGHTSPRING HEALTH SERVICES INC - Q1 NET REVENUE INCREASES 25.6% TO $3.614 BILLION
- Revenue Growth: BrightSpring Health Services reported a 25.6% increase in net revenue for Q1, reaching $3,614 million.
- Financial Performance: The significant rise in revenue indicates strong financial performance and growth within the health services sector.
See More
BrightSpring Completes Sale of ResCare Community Living to Sevita
- Transaction Background: BrightSpring Health Services has completed the sale of ResCare Community Living, a move that underscores a commitment to continuity of care for individuals with intellectual and developmental disabilities while ensuring workforce stability.
- Strategic Transition Significance: CEO Jon Rousseau stated that the divestiture was aimed at ensuring high-quality, innovative care for clients, marking a strategic shift for both BrightSpring and Sevita as they focus on their respective missions.
- Service Expansion Potential: Sevita CEO Philip Kaufman highlighted that the acquisition will leverage the strengths of both organizations, enhancing programming and expected to benefit more individuals in need of high-quality support, thereby improving overall service quality.
- Industry Impact: BrightSpring serves over 450,000 customers daily and consistently demonstrates industry-leading quality metrics, and this transaction is expected to further solidify its market position in the complex care sector.
See More
